Novo Nordisk's obesity therapy Wegovy put in another strong sales performance ... pharmaceutical ingredients and finished injectable products – that will result in "continued periodic supply ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

The weight-loss drugmaker's Wegovy and Ozempic are among the most closely watched new medications in recent history, but face ...

Danish drugmaker Novo Nordisk (NVO) reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's expectations and bumping its stock up more than 4% at market open.

Novo Nordisk has such a blockbuster with Wegovy and Ozempic ... Novo Nordisk also manufactures and markets pharmaceutical products related to hormone therapy, hemophilia and growth disorders.

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Ironically, Ozempic and Wegovy, as with many of Novo Nordisk’s other products, were created primarily for treating diabetes. The weight-loss factor has become a very profitable and unintended ...

And the deal will result in a hit of $1.26 billion this year from debt financing. Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, ...